Printer Friendly

HEALTHDYNE ANNOUNCES FINAL 1991 YEAR END RESULTS

 HEALTHDYNE ANNOUNCES FINAL 1991 YEAR END RESULTS
 MARIETTA, Ga., March 5 /PRNewswire/ -- Healthdyne, Inc.


(NASDAQ: HDYN) today announced the final results for the year and quarter ended Dec. 31, 1991.
 The final year-end results reflect the resolution of the matters described in the company's Feb. 21, 1992, preliminary release related to certain transactions under the company's stock option plans. Revenues increased to $191 million, which is a 38 percent increase over the $138 million from 1990. Net earnings for the year, which were preliminarily reported at $12.9 million or $0.82 per share, will be reduced by a noncash nonrecurring corporate expense of $0.16 per share, or $2.4 million with a corresponding addition to paid-in capital. Net earnings, including this expense, for the year ending Dec. 31, 1991, were $10.5 million, or $0.67 per share. This compares to net earnings of $8 million, or $0.50 per share for 1990. Earnings for the fourth quarter of 1991 were unaffected by the noncash, nonrecurring corporate expense.
 Revenues for the fourth quarter increased 44 percent to $55 million, compared to $38 million in the equivalent quarter in 1990, and net earnings for the quarter increased 488 percent to $4 million, or $.26 per share, from $700,000, or $.05 per share.
 Parker H. Petit, chairman of the board and chief executive officer, commented that: "I feel that 1991 was a very successful year for Healthdyne with our operating performance up significantly over 1990. All three of our operating units performed very well, and we expect their excellent performance to continue."
 Healthdyne is a national provider of high-tech home care medical services, including infusion therapy through Home Nutritional Services, its partially owned subsidiary, and home obstetrical care through Healthdyne Perinatal Services. In addition, Healthdyne manufactures high-tech home care products through its Healthdyne Technologies division.
 HEALTHDYNE, INC. AND SUBSIDIARIES
 CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
 (Amounts in thousands, except per share amounts)
 3 mos. ended Dec. 31 1991 1990
 (unaudited)
 Revenues $54,712 $38,073
 Cost of revenues 23,809 17,490
 Gross profit 30,903 20,583
 Selling and admin. expenses 18,935 15,162
 Provision for doubtful
 accounts 4,104 3,036
 Noncash compensation resulting
 from stock option exercises --- ---
 Research and development
 expenses 616 455
 Operating profit 7,248 1,930
 Interest income 334 325
 Interest expense (186) (186)
 Other income (expense), net (15) (3)
 Minority interest in earnings of
 partnerships (195) ---
 Earnings before income tax expense
 and minority interest in net
 earnings of subsidiary 7,186 2,066
 Income tax expense 2,000 528
 Earnings before minority interest
 in net earnings of subsidiary 5,186 1,538
 Minority interest in net earnings
 of subsidiary 1,070 838
 Net earnings $ 4,116 $ 700
 Net earnings per common share
 and common share equivalent $ .26 $ .05
 Weighted average number of
 common shares and common
 share equivalents 15,830 15,205
 12 mos. ended Dec. 31 1991 1990
 Revenues $191,432 $138,312
 Cost of revenues 83,645 65,500
 Gross profit 107,787 72,812
 Selling and admin. expenses 66,303 50,518
 Provision for doubtful
 accounts 15,199 10,467
 Noncash compensation resulting
 from stock option exercises 2,434 ---
 Research and development
 expenses 2,236 1,585
 Operating profit 21,615 10,242
 Interest income 965 2,280
 Interest expense (744) (626)
 Other income (expense), net (43) 2,821
 Minority interest in earnings of
 of partnerships (544) ---
 Earnings before income tax expense
 and minority interest in net
 earnings of subsidiary 21,249 14,717
 Income tax expense 6,945 3,634
 Earnings before minority interest
 in net earnings of subsidiary 14,304 11,083
 Minority interest in net earnings
 of subsidiary 3,807 3,043
 Net earnings 10,497 8,040
 Net earnings per common share
 and common share equivalent $ .67 $ .50
 Weighted average number of
 common shares and common
 share equivalents 15,636 15,966
 Consolidated Condensed Balance Sheets
 (Amounts in thousands)
 ASSETS 12/31/91 12/31/90
 Current assets:
 Cash and short-term
 investments $ 23,015 $ 15,522
 Trade accounts receivable,
 net 74,165 55,526
 Inventories 13,063 12,799
 Deferred income taxes 680 3,048
 Other current assets 4,702 6,165
 Total current assets 115,625 93,060
 Property and equipment, net 15,252 12,437
 Goodwill and other intangibles,
 net 5,056 4,457
 Other assets 2,649 658
 Total $ 138,582 $ 110,612
 LIABILITIES AND SHAREHOLDERS' EQUITY
 Current liabilities:
 Current installments of long-term
 debt and obligations under
 capital leases $ 516 $ 674
 Accounts payable, principally
 trade 8,861 6,561
 Other current liabilities 11,813 8,809
 Total current liabilities 21,190 16,044
 Long-term debt and obligations
 under capital leases, excluding
 current installments 6,655 4,362
 Deferred income taxes 6,766 6,766
 Other long-term liabilities 604 729
 Total liabilities 35,215 27,901
 Min. interest in subsidiaries 23,352 17,631
 Shareholders' equity 80,015 65,080
 Total $ 138,582 $ 110,612
 -0- 3/5/92
 /CONTACT: Donald R. Millard of Healthdyne, 404-423-4529/
 (HDYN) CO: Healthdyne, Inc. ST: Georgia IN: HEA SU: ERN


BR-BN -- AT009 -- 5432 03/05/92 12:10 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 5, 1992
Words:852
Previous Article:AFRICAN DEVELOPMENT BANK SENIOR DEBT RATED 'AAA' BY FITCH -- FITCH FINANCIAL WIRE --
Next Article:DIGITAL AND MASSPORT LINK FOR CENTRAL EUROPE SEMINAR
Topics:


Related Articles
HOME NUTRITIONAL SERVICES ANNOUNCES PRELIMINARY SECOND QUARTER RESULTS; APPOINTS NEW CHIEF EXECUTIVE OFFICER
HEALTHDYNE ANNOUNCES FINAL SECOND QUARTER RESULTS
HEALTHDYNE ANNOUNCES THIRD QUARTER RESULTS
HEALTHDYNE ANNOUNCES 1992 FINANCIAL RESULTS
HEALTHDYNE ANNOUNCES THIRD QUARTER EXPECTATIONS FOR HOME OBSTETRICAL CARE SUBSIDIARY
HEALTHDYNE ANNOUNCES 1993 FINANCIAL RESULTS
HEALTHDYNE ANNOUNCES SECOND QUARTER RESULTS AND FORMATION OF NEW SUBSIDIARY
HEALTHDYNE ANNOUNCES THIRD QUARTER RESULTS
HEALTHDYNE ANNOUNCES PROPOSED SPIN-OFF OF HEALTHDYNE TECHNOLOGIES AND 1994 FINANCIAL RESULTS
HEALTHDYNE ANNOUNCES SECOND QUARTER RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters